Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy (Q47893061)

6 February 2018

title

Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy (English)

1 reference

6 February 2018

author

Catherine Klersy

5

1 reference

6 February 2018

Angelo Auricchio

13

object named as

Angelo Auricchio

1 reference

6 February 2018

2

François Regoli

1 reference

6 February 2018

Tiziano Moccetti

12

object named as

Tiziano Moccetti

1 reference

6 February 2018

Francesco F Faletra

7

object named as

Francesco Faletra

1 reference

6 February 2018

author name string

Cecilia Fantoni

1

1 reference

6 February 2018

Ali Ghanem

3

1 reference

6 February 2018

Santi Raffa

4

1 reference

6 February 2018

Antonio Sorgente

6

1 reference

6 February 2018

Massimo Baravelli

8

1 reference

6 February 2018

Luigi Inglese

9

1 reference

6 February 2018

Jorge A Salerno-Uriarte

10

1 reference

6 February 2018

Helmut U Klein

11

1 reference

6 February 2018

publication date

4 March 2008

1 reference

6 February 2018

European Journal of Heart Failure

published in

1 reference

6 February 2018

volume

10

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

298-307

1 reference

6 February 2018

Diabetes and cardiovascular disease. The Framingham study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Role of diabetes in congestive heart failure: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Functional class in patients with heart failure is associated with the development of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Vagolytic effect of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.006

10.1016/J.EJHEART.2008.01.006

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018